Mayne Pharma Group(MAYNF)
$2.20-0.10 (-4.15%)
MAYNF
Mayne Pharma Group earnings date
$2.20
At close:-0.10 (-4.15%)
Mayne Pharma Group (MAYNF) Q2 2023 Earnings Report
24 Followers
MAYNF Q2 2023 EPS Results
- Actual EPS
- -$0.05
- Consensus EPS
- -$0.55
- Beat/Miss
- Beat by +$0.50
- One Year Ago EPS
- -$0.37
MAYNF Q2 2023 Revenue Results
- Actual Revenue
- $69.29M
- Expected Revenue
- $54.59M
- Beat/Miss
- Beat by +$14.70M
- YoY Revenue Growth
- -48.50%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 02/27/2023
- Time
- After Close
- Conference Call
- Monday, February 27, 2023
MAYNF Upcoming Earnings
Mayne Pharma Group's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MAYNF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2027 (Q2) | -0.11- | -0.1 | ― | ― |
| Aug 26, 2026 | 2026 (Q4) | -0.23-0.25 | -0.58 | 56.84% (+0.33) | |
| Feb 22, 2026 | 2026 (Q2) | ―-0.10 | -0.17 | 40.71% (+0.07) | |
| Aug 28, 2025 | 2025 (Q4) | 0.00-0.58 | 0 | -84200.00% (-0.58) | |
| Feb 25, 2025 | 2025 (Q2) | -0.09-0.17 | -0.6 | 71.18% (+0.43) | |
| Aug 22, 2024 | 2024 (Q4) | -0.150.00 | -1.37 | 100.05% (+1.37) | |
| Feb 25, 2024 | 2024 (Q2) | -0.32-0.60 | -0.05 | -1025.64% (-0.55) | |
| Aug 30, 2023 | 2023 (Q4) | -0.39-1.37 | -0.82 | -67.64% (-0.55) | |
| Feb 27, 2023 | 2023 (Q2) | -0.55-0.05 | -0.37 | 85.69% (+0.32) | |
| Aug 25, 2022 | 2022 (Q4) | -0.19-0.82 | -0.02 | -3317.14% (-0.80) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
